-
, develop and understand the CRISPR-Cas9 system that forms the base of the platform, and develop and implement methods to evaluate its safety in a clinical setting. We will use the gene editing technologies
-
-duct-on-a-chip, in particular). Relevant interventions include drug-screening experiments, co-culture experiments and system modifications. The aim is to identify potential drug candidates for chronic
-
environmental history) but it may also be incorporated in UiO’s Sustainability certificate . The course answers a key challenge identified by the Norwegian educational system, namely to address prevailing
-
-disciplinary environment. Organization skills. Ability to work independently and take initiatives. Clarity in communication. We offer Salary 575 400 - 657 300 NOK per annum depending on qualification in a
-
18 Apr 2024 Job Information Organisation/Company University of Oslo Research Field Medical sciences Researcher Profile Recognised Researcher (R2) Country Norway Application Deadline 8 May 2024 - 23
-
the tumor. The Precision Immunotherapy Alliance (PRIMA) will use the immune system of healthy donors to overcome these bottlenecks and extend cell-based immunotherapy to a range of blood and solid cancers
-
21 Mar 2024 Job Information Organisation/Company University of Oslo Research Field Psychological sciences Researcher Profile Recognised Researcher (R2) Country Norway Application Deadline 14 Apr
-
20 Mar 2024 Job Information Organisation/Company University of Oslo Research Field Medical sciences Researcher Profile Recognised Researcher (R2) Country Norway Application Deadline 23 Apr 2024 - 23
-
-lab molecular techniques and phylogenetics hands-on experience with building DNA barcode reference libraries experience with organizing events (e.g. workshops/field courses) team- and networking skills
-
administrative and organizational skills and experience, and familiarity with planning and organizing events. We offer Salary NOK 575 400 - 657 300 per annum depending on qualifications A professionally